MULTICENTER CONTROLLED RANDOMIZED DOUBLE-BLIND PLACEBO STUDY OF MINAPRINE IN ELDERLY PATIENTS SUFFERING FROM PROLONGED DEPRESSIVE REACTION

被引：8

作者：

PARNETTI, L

SOMMACAL, S

LABATE, AMM

SENIN, U

机构：

[1] Gerontologia E Geriatria, E Centro Ricerche Gerontologiche, Università Degli Studi di Perugia, Dipartimento di Medicina Clinica, Patologia E Farmacologia, Perugia, 06122, via Eugubina

[2] Sanofi-Winthrop, Milan

[3] Istituto di Clinica Medica E Gastroenterologia, University of Bologna, Bologna

来源：

DRUG INVESTIGATION | 1993年 / 6卷 / 04期

关键词：

D O I：

10.1007/BF03259242

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A multicentre randomised double-blind controlled study using minaprine vs placebo was carried out in 130 elderly patients suffering from prolonged depressive reaction (ICD 9, 309. 1). After a 15-day run-in period, either oral minaprine 100mg twice daily or placebo was given for 90 days (double-blind period) and then both groups were treated with minaprine at the same dosage (open period). Depressive symptoms were assessed by means of the 'Evaluation Clinique de la Personnalite' scale and the Symptom Rating Test. At the end of the double-blind period, the minaprine group showed improvement in the majority of psychological parameters, while after the open period the 'ex-placebo group' showed a more pronounced improvement, reaching approximately the same level as the minaprine group. Tolerability was highly satisfactory in both groups. The high frequency and clinical relevance of depression due to stressful events in the elderly supports the therapeutic value of minaprine, an atypical antidepressant agent devoid of anticholinergic effects.

引用

页码：181 / 188

页数：8

共 23 条

[11]

Israel L., Ohlmann T.H., Hugonot L., Drouet d'Aubigny G., Echelle clinique d’evaluation de la personnalité. Validation par analyse factorielle en geriatrie, Encephale, 6, pp. 81-91, (1980)

[12]

Kellner R., Sheffield B.F., A self-rating scale of distress, Psychological Medicine, 3, pp. 88-100, (1973)

[13]

Mikus P., Biziere K., Bentel U., A controlled study of minaprine and nomifensine in outpatients with masked depression, Clinical Trials Journal, 22, pp. 477-488, (1985)

[14]

Montgomery S.A., Baldwin D.S., Priest R.G., Steinert J., Patel A., Et al., Minaprine and dose response in depression. An investigation for 2 fixed doses of minaprine compared with imipramine, Pharmacopsychiatry, 24, pp. 168-174, (1991)

[15]

Musetti L., Perugi G., Soriani A., Rossi V.M., Cassano G.B., Et al., Depression before and after age 65, British Journal of Psychiatry, 155, pp. 330-336, (1989)

[16]

Diagnosis and treatment of depression in late-life, Journal of the American Medical Association, 268, pp. 1018-1024, (1992)

[17]

Passeri M., Cucinotta D., De Mello M., Biziere K., Comparison of minaprine and placebo in the treatment of Alzheimer’s disease and multi-infarct dementia, International Journal of Geriatric Psychiatry, 2, pp. 97-103, (1987)

[18]

Radmayr E., Biziere K., Bentel U., Minaprine and maprotiline in endogenous depression: a double-blind controlled study, Clinical Trials Journal, 23, pp. 100-109, (1986)

[19]

Salzmann E., Pieschl D., Gierend M., Minaprine and imipramine in major depressive disorders. A multicentre double-blind study, Journal of Drug Development, 3, pp. 27-36, (1990)

[20]

Siegel S., Non parametric statistics for the behavioral sciences, (1956)

← 1 2 3 →